A Carnegie Mellon University-led team of researchers has secured an award of up to $34.9 million from the Advanced Research Projects Agency for Health (ARPA-H).
Bioelectronic ‘living pharmacy’ implant could transform diabetes and obesity care
- Post author:
- Post published:October 3, 2024
- Post category:uncategorized